Page 69 - Amgen News Today

The S&P500 ended in the green for the 5th time in 6 sessions, the same for the Nasdaq with +0.35%, with the Dow Jones coming out on top with +0.38%.Tesla +15.3% , Boeing and Apple supported the 3...

Key events for UK wealth managers for the week starting 29 April

Amgen’s stock offers investors a yield slightly above 3%, supported by 12 years of consistent growth. Despite a 6% year-to-date decline, the stock is rated as…

Adell Harriman & Carpenter Inc. boosted its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 17,263 shares of the medical research company’s stock after purchasing an additional 170 shares during the period. Adell Harriman & Carpenter Inc.’s holdings in Amgen were worth $4,972,000 as […]

Around the world, 100 companies have debuted weight-loss medications, which have become a multimillion-dollar business. Novo Nordisk’s Ozempic is currently the best-known, but it’s far from the only option

Raymond James & Associates lowered its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 6.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,079,536 shares of the medical research company’s stock after selling 74,674 shares during the period. […]

Transcend Capital Advisors LLC reduced its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,501 shares of the medical research company’s stock after selling 101 shares during the […]

Coming up: Fed rate decision, jobs report, and earnings from Apple, Amazon, AMD

Fulton Breakefield Broenniman LLC trimmed its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 10.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,313 shares of the medical research company’s stock after selling 821 shares during the period. Fulton […]

Fulton Breakefield Broenniman LLC lessened its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 10.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,313 shares of the medical research company’s stock after selling 821 shares during the quarter. Fulton […]